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The cystic fibrosis transmembrane conductance regulator
(CFTR) is a unique ATP-binding cassette (ABC) ion channel
mutated in patients with cystic fibrosis. The most common
mutation, deletion of phenylalanine 508 (F508) and many
other disease-associated mutations occur in the nucleotide
binding domains (NBD) and the cytoplasmic loops (CL) of the
membrane-spanning domains (MSD). A recently constructed
computationalmodel of theCFTR three-dimensional structure,
supported by experimental data (Serohijos, A. W., Hegedus, T.,
Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Rior-
dan, J. R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 3256–3261)
revealed that several of these mutations including F508 dis-
rupted interfaces between these domains. Here we have used
cysteine cross-linking experiments to verify all NBD/CL inter-
faces predicted by the structural model and observed that their
cross-linking has a variety of different effects on channel gating.
The interdomain contacts comprise aromatic clusters impor-
tant for stabilization of the interfaces and also involve the
Q-loops and X-loops that are in close proximity to the ATP
binding sites. Cross-linking of all domain-swapping contacts
betweenNBDs andMSDcytoplasmic loops in opposite halves of
the protein rapidly and reversibly arrest single channel gating
while those in the same halves have lesser impact. These results
reinforce the idea that mediation of regulatory signals between
cytoplasmic- and membrane-integrated domains of the CFTR
channel apparently relies on an array of precise but highly
dynamic interdomain structural joints.
The cystic fibrosis transmembrane conductance regulator
(CFTR)3, the mutation of which causes cystic fibrosis (CF),
belongs to the superfamily of ATP-binding cassette (ABC) pro-
teins but functions as an ion channel rather than an active
transporter. The chloride channel activity is crucial for main-
taining salt and fluid homeostasis in epithelial tissues (1). In
patients with CFTRmutations that compromise its maturation
or channel activity, the airway surface liquid volume is dimin-
ished, impeding mucociliary clearance (2, 3). The absence of
functional CFTR also impairs submucosal gland secretion (4).
Like many other ABC family proteins, CFTR (also known as
ABCC7) contains two membrane-spanning domains (MSDs)
and two nucleotide-binding domains (NBDs), with an addi-
tional unique R domain (Fig. 1). While many ABC proteins are
multisubunit proteins composed of two identical NBDs and
MSDs, CFTR is a single polypeptide containing two distinct
NBDs andMSDs. The proper folding of the individual domains
and the interactions between these domains during or after
protein synthesis are essential for CFTR assembly, a process
that is inefficient with the majority of CFTR being degraded at
the endoplasmic reticulum by the proteasome (5, 6). The most
prevalent CF-causing mutation is the deletion of a phenylala-
nine at position 508 (F508). Recent studies suggest that the
folding kinetics of NBD1 and the interdomain interactions
between MSDs and the NBDs are disrupted by this mutation
(7–9), although the crystal structures of isolated wild-type and
mutant NBD1 show no major alteration in its overall three-
dimensional structure (10).
Control of CFTR channel activity is modulated by the phos-
phorylation of the R domain by protein kinase A, which allows
the regulation of gating by ATP binding at the NBD1/NBD2
interface. Stable binding of ATP at NBD1 and binding and
hydrolysis of ATP at NBD2, together with R domain phospho-
rylation, may alter allosteric interactions between these
domains and impact the channel gating cycle (11–13).
Although considerable progress has been made toward under-
standing the integrated control of CFTR channel gating by
phosphorylation and ATP binding/hydrolysis (12), details at
the level of interactions of specific secondary and tertiary struc-
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tural elements remain to be elucidated and require knowledge
of the three-dimensional structure.
As yet, no high resolution crystal structure of any eukaryotic
ABC proteins is available. However, the crystal structures of
several bacterial ABC transporter proteins have been recently
solved (14–18). Of particular interest is the structure of the
bacterial exporter Sav1866, which shows its NBDs in close con-
tact with bothMSDs, a configuration that is unlike those of the
importers (BtuCD,ModBC,HI1470/71 and theEscherichia coli
maltose transporter), which show each of their MSD in contact
solely with one NBD. Although CFTR functions as a channel, it
belongs to the exporter subclass of the ABC family. In our
recentwork, amolecularmodel ofCFTRwas constructed based
on its homology to Sav1866. From themodel, we predicted and
confirmed experimentally the interdomain interactions
betweenCL2 (MSD1) andNBD2 and betweenCL4 (MSD2) and
NBD1 (19). The later interaction between NBD1 and CL4 is
most crucial to CFTR biogenesis and assembly because of the
known sensitivity of CFTR conformationalmaturation tomany
disease-associated mutations in CL4 as well as NBD1 (20). Sin-
gle channel activity measurements also show that both inter-
faces are important for the regulation of channel gating as
cross-linking of Cys on either side of these interfaces arrests
channel gating. This observation, corroborated by rate equilib-
rium-free energy relationship (REFER) analysis of the single
channel kinetics, suggest that these interfaces act as connecting
joints between MSDs and NBDs, thus coordinating movement
on either side of the contact (19).
Many disease-causing mutations also occur in other cyto-
plasmic loops such as CL1 and CL3, compromising CFTRmat-
uration and channel function (21, 22), which suggests that these
regions of CFTR may also play an important role in interdo-
main interactions and channel regulation. Further identifica-
tion and analysis of the CL/NBD interfaces should help under-
standing of how these mutations disrupt interdomain
interactions during CFTR biosynthesis and how the signals of
ATP binding and hydrolysis at NBDs are transmitted toMSDs.
EXPERIMENTAL PROCEDURES
Antibodies—Mouse monoclonal CFTR antibodies to an
N-terminal fragment (mAb 13-4, IgG1), NBD2 (mAb 596,
IgG2b), and R domain (mAb 450, IgG1) were generated as
described (9). Goat anti-mouse IgG-IR800, IgG1-IR800, and
IgG2b-IR680 were from LiCor Corp.
Construction and Expression of Mutants—Cysteine (Cys)
was introduced into the Cys-less CFTR construct in
pcDNA3 vector by the Stratagene Quick Exchange protocol
as described (19). A stop codon (TAA) was introduced at
residue Glu-1172 to produce the NBD2 construct, 1172X
(9). 5-GGACCCCAGCGCCCGAGAGACCATGGAAGGT-
AAACCTACCAAGTCAACC-3 and its reverse primer were
used to make an NBD2-containing construct (residues 1172–
1480). Point mutations and PCR-generated DNA fragments
were confirmed by automated DNA sequencing (UNC-CH
Genome Analysis Facility).
Human embryonic kidney 293 (HEK) cells were transiently
transfected using Effectene transfection reagent (Qiagen)
according to themanufacturer’s instructions. To promotemat-
uration of Cys-less CFTR variants, 24 h after transfection, HEK
cells were incubated at 27 °C for 48 h before the cross-linking
experiment. For stable expression, constructs were cotrans-
fected with pNUT plasmid into baby hamster kidney (BHK-21)
cells, which were selected and maintained in methotrexate-
containing medium (23). To phosphorylate CFTR, cells were
incubated for 10 min with 10 M forskolin, 100 M DiBu-
cAMP, and 1 mM 3-isobutyl-1-methylxanthine before harvest-
ing. This stimulationmixturewas also present during the cross-
linking reaction.
Isolation of Membrane Vesicles and Single-Channel
Measurements—Membrane vesicles were isolated from BHK
or HEK cells expressing variants of Cys-less CFTR as described
previously (19). To phosphorylate CFTR, membranes were
treated with 100 units/ml PKA (Promega) in the presence of 2
mM ATP and 2 mM MgCl2 for 15 min at room temperature,
sonicated briefly, and incubated for another 15 min to achieve
complete phosphorylation. Phosphorylation was confirmed by
the diminution of the signal detected by the phosphorylation-
sensitivemAb 450. Single-channel recordings were collected as
previously described (19, 24).
Cross-linking inWhole Cells andMembrane Vesicles—Disul-
fide cross-linking in cells with bifunctional methanethiosulfon-
ate (MTS, Toronto Research Chemicals) cross-linkers with
spacer arms ranging from 3.9 to 24.7 Å was performed as
described (19). To cross-link CFTR in vesicles, membranes (1
mg/ml total proteins) were incubated with 20 MMTS reagent
for 15min at room temperature. The cross-linking reactionwas
stopped with Laemmli sample buffers with or without DTT.
Proteins were resolved with 7.5% SDS-PAGE and CFTR
detected with mAb 596 and secondary goat anti-mouse IgG-
IR800 using the Odyssey infrared scanner (LiCor Corp.). For
dual antibody labeling, isotype-specific secondary antibodies
labeled with different infrared (IR) dyes were used. Specifically,
goat-anti-mouse IgG1-IR800 and IgG2b-IR680 were used to
detect mAb 450 and mAb 596, respectively.
Limited Trypsin Digestion—For limited trypsin digestion,
BHK membranes were resuspended at 1 mg of protein/ml in a
buffer containing 40mMTris-HCl, pH7.4, 2mMMgCl2, and 0.1
mM EGTA. Membrane proteins were first treated with 20 M
M8M cross-linker for 15 min at room temperature and centri-
fuged to remove cross-linker before trypsin digestion. Mem-
braneswere incubated on icewith 240 and 480g/ml of TPCK-
treated trypsin for 15 min, and digestion was stopped with
excess soybean trypsin inhibitor. CFTR tryptic fragments sep-
arated on 4–20% gradient gels (Bio-Rad) were detected by
Western blots probed with mAb 13-4.
RESULTS
Aromatic Clusters Mediate Domain-swapping Interactions—
Many disease-associatedCFTRmutations occur in cytoplasmic
loops, compromising CFTR maturation and channel activity
(20–22). Determination of how these loops interact with other
domains may help the understanding of how these mutations
disrupt CFTR biosynthesis and channel activity. We have con-
structed a three-dimensional model of CFTR based on Sav1866
and shown that there are close contacts between CL2 and
NBD2, and between CL4 and NBD1 (19) (Fig. 1). This configu-
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ration supported the so-called “domain-swapping” where each
MSD interacts with the NBD in the opposite half of the mole-
cule as was earlier observed in Sav1866 (14) and also in MsbA
(25).
A striking feature of the CL4/NBD1 interface is the interac-
tion of Phe-508 with a cluster of aromatic residues (Phe-1068,
Tyr-1073, and Phe-1074) in CL4, which may serve to stabilize
this crucial interface (19). The structural model predicts an
analogous aromatic cluster in the interface between CL2 (Tyr-
275) and NBD2 (Phe-1294, Phe-1296, and Tyr-1307). To verify
these specific interactions, we performed cross-linking experi-
ments in HEK cells expressing a Cys-less CFTR construct con-
taining the Cys pair 276C and Y1307C (Fig. 2A). The 276 and
1307 sites could be cross-linked using the MTS reagents M3M
and M8M, but to a lesser extent with M1M and M17M, sug-
gesting that the two residues are in relatively close contact.
These cross-linking results confirm the existence of an analo-
gous aromatic cluster between CL2 and NBD2.
Q- and X-Loops of Both NBDs Also Participate in CL2/NBD2
and CL4/NBD1 Interactions—Conformational changes due to
ATP binding and hydrolysis at the NBD1/NBD2 interface may
be transmitted to the MSDs through the CL/NBD interface
contacts. Thus it is important to determine whether or not
these interfaces are spatially proximal to the ATP binding sites.
In agreementwithwhat is predicted by ourmodel, wewere able
to cross-link residue pairs W496C/T1064C, M498C/L1065C
(19), which proves that indeed CL4 also interacts with NBD1
through the so called Q-loop (Q493). The Q-loop connects the
canonical -helical subdomain containing the ABC signature
with the core subdomain containing Walker A and Walker B
motifs (26–28). In the histidine permease structure, the side
chain of the Q-loop glutamine (Q100) contacts the -phos-
phate of ATP via a water molecule (28). Analogous to the inter-
action of CL4 with the Q-loop of NBD1, our model also predicts
a close contact between CL2 and the Q-loop (Q1291) of NBD2.
The successful cross-linking of the residue pairs N268C (CL2)
and F1294C (NBD2) by theMTS reagents of various spacer arm
lengths confirmed this contact (Fig. 2A). The interaction of the
Q-loops with the CLs observed in the Sav1866 crystal structure
and identified by cross-linking in CFTR is also observed inABC
importers such as BtuCD, ModBC, HI1470/1, and the maltose
transporter (15–18). However, one
feature that is unique to the Sav1866
structure is that its so-called X-loop
(469TEVGERG) in the NBD inter-
acts with both CL1 and CL2. The
X-loop sequence is conserved in
exporters but not in importers (14).
Moreover, X-loops are in close
proximity to the ABC signature
motifs, making them also good can-
didates for the transmission of sig-
nals of ATP binding/hydrolysis at
the NBDs to the MSDs. Sequence
alignment of CFTR with Sav1866
indicates that in CFTR, Glu-543
(NBD1), and Asp-1341 (NBD2) cor-
respond to Glu-473 of the Sav1866
X-loop. Cys pair cross-linking
experiments showed that indeed
E543C could be cross-linked with
both T966C (CL3) and T1057C
(CL4, Fig. 2B), while D1341C was in
close contact with both L172C
(CL1) and N268C (CL2, Fig. 2C).
CL/NBD Interfaces within Each
Half of CFTR—So far, we have
only confirmed the cross-linking
FIGURE 1. CFTR scheme. CFTR is composed of two nucleotide binding
domains (NBD1 and NBD2), two membrane-spanning domains (MSD1 and
MSD2), and a regulatory region (R domain). Indicated by arrows are the con-
firmed interactions between the NBDs and the CLs of the MSDs.
FIGURE 2. Contact interfaces of CLs with opposite NBDs. HEK 293 cells transiently transfected with Cys-less
CFTR containing Cys pairs introduced at different interfaces between cytoplasmic loops and NBDs were incu-
bated with 200 M MTS reagents of different spacer arm lengths. Cell lysates in SDS-PAGE sample buffer with
or without DTT were subjected to Western blot analysis using CFTR antibody mAb 596. Cross-linked proteins
migrate above 250 kDa. A, 276C/Y1307C and N268C/F1292C at the CL2/NBD2 interface involving an aromatic
cluster and the Q-loop. B, T966C/E543C at the CL3/NBD1 interface and T1057C/E543C at the CL4/NBD1 inter-
face at the X-loop of NBD1. C, L172C/D1341C at the CL1/NBD2 interface and N268C/D1341C at the CL2/NBD2
interface at the X-loop of NBD2. The three bands, X, C, and B, represent the cross-linked, the mature complex
glycosylated, and the immature core glycosylated CFTR, respectively.
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betweenMSDs with their opposite NBDs through CLs, i.e.CL1
and CL2 with NBD2, and CL3 and CL4 with NBD1. However,
contact interfaces of the N-terminal cytoplasmic loops in each
MSD (CL1 and CL3) with NBDs of the same half of the mole-
cule have not been established in any eukaryotic ABC proteins.
According to our Sav1866-based CFTR model, CL1 and CL3
should contact both NBDs, as shown in the scheme in Fig. 1. To
confirm these contacts in the case of CL3 and NBD2, we
designed several Cys pairs from CL3 (M961C and S962C) and
NBD2 (L1260C and L1261C) (Fig. 3A). Cross-linking experi-
ments were carried out in HEK cells overexpressing Cys-less
CFTR with these Cys pairs. In constructs containing the Cys
pairs M961C/L1261C (Fig. 3A), M961C/L1260C, and S962C/
L1261C (supplemental Fig. S1A), MTS reagent treatment pro-
duced a slightly, albeit distinguishably, faster moving band,
which could be reversed by DTT. We hypothesized that this
different mobility shift pattern may be due to the smaller num-
ber of amino acids between these cross-linked Cys pairs (300
amino acids) than those between CLs and opposite NBDs
(400 to 1200 amino acids), which produce a clear cross-
linked band that migrates much slower (for example Fig. 2). A
faster moving band after cross-linking was also observed when
cross-linking T123C (CL1) with S428C (NBD) of themultidrug
ABC transporter BmrA (29), which is separated by300 amino
acids between the cross-linked cysteines. Cross-linking of Cys
pairs between CL3 and NBD2 was also confirmed with co-ex-
pression of constructs of Cys-less NBD2 CFTR containing
M961C together with the Cys-less NBD2 fragment containing
L1261C in HEK cells (supplemental Fig. S1, B and C).
Baker et al. (30) reported NMR data indicating that CL1
binds to NBD1 in a phosphorylation-dependent mechanism,
which may be mediated by a short sequence in NBD1 termed
the regulatory insertion (RI). The absence of theRI in the crystal
structure of the human NBD1 and the elevated b-factor in the
mouse NBD1 structure (10, 26) indicate that this region is
highly dynamic, potentially adopting multiple conformations
in solution. In the construction of the whole CFTR model (19),
wemodeled the RI conformation such that it points toward the
solution, as suggested by one of the crystal structures of the
human NBD1 with Phe-508 deleted (10). However, another
possible conformation that may be adopted by the RI is sug-
gested by the crystal structure of the mouse NBD1 (26), which
shows its RI “flipped” toward the NBD1/NBD2 interface and
CL1 (Fig. 3B).
Based on the latter model, we attempted to detect cross-
linking of the residue pairs V171C/E407C andV171C/L408C in
the whole protein, but did not observe any indication of cross-
linking of the mature band (supplemental Fig. S2A). Because
the number of amino acids between CL1 and NBD1 (240
amino acids) is even smaller than that between CL3 and NBD2
(300 amino acids), we speculated that any mobility shift
caused by cross-linking of CL1 and NBD1, if it existed, may not
be detectable with the resolution of SDS-PAGE. We also spec-
ulated that the mobility shift between CL1 and NBD1might be
detected if the molecular fragments were smaller. To test this
hypothesis, membrane vesicles were prepared from BHK cells
overexpressing Cys-less CFTR containing V171C and L408C.
To obtain cross-linked smaller fragments of CFTR, membrane
vesicles were subjected to limited trypsin digestion after M8M
treatment. The digested proteins were then resolved with gra-
dient SDS-PAGE, and the CFTR fragments were detected by
Western blot using the N-terminal CFTR antibody mAb 13-4.
As shown in Fig. 3B, limited trypsin digestion produced a band
of 120 kDa in control membrane vesicles (highlighted in the
rectangle, indicated by the black arrow). This band was unique
to the Cys-less CFTR and was not previously observed in wild-
type CFTR (9). M8M treatment caused the band tomove faster
(apparent molecular mass 110 kDa, indicated by the gray
arrow), which could be reversed by DTT. We found similar
results for the Cys pair V171C and E407C (supplemental Fig.
2B), but not with a Cys pair introduced at Gln-958 and Leu-
1261 (supplemental Fig. S2C), confirming that the faster mov-
ing CFTR fragment was indeed due to the cross-linking at the
CL1/NBD1 interface. Contrary to what was found by NMR
analysis using a synthetic CL1 peptide and purified NBD1 (30),
our cross-linking experiments using a functional full-length
CFTR, fully integrated in themembrane, detected a CL1/NBD1
interaction which was independent of PKA phosphorylation
(supplemental Fig. S2B). No cross-linking was detected when
Cys pairs were introduced at L172C/E543C, T966C/D1341C,
V171C/L1261C, or M961C/L408C, which are not predicted to
be in association in the structuralmodel (supplemental Fig. S3).
PKA Phosphorylation Does Not Affect CL/NBD Cross-
linking—Positioned at a crucial contact point between MSDs
and NBDs, CLs are good structural candidates for transmitting
the conformational signals initiated by ATP binding/hydrolysis
to the MSDs to regulate channel gating. Previously, we have
found that the interfaces at CL2/NBD2 and CL4/NBD1 are not
strongly influenced by PKA stimuli or by the binding of AMP-
PNP, or by trapping of ADP-vanadate at the NBDs (19). In the
present study, we also determined whether our newly detected
FIGURE 3. Contact interfaces of CLs with NBDs within each half of CFTR.
A, cross-linking at interfaces between CL3 and NBD2. Transiently transfected
HEK cells were incubated with 200 M MTS reagents, and cross-linking was
detected as described under “Experimental Procedures.” The cross-linked
proteins that moved faster than the mature C band with a Cys pair introduced
at Met-961 and Leu-1261 are marked with *. B, cross-linking at interface
between CL1 and NBD1. Membrane vesicles prepared from BHK cells overex-
pressing Cys-less CFTR containing the Cys pair V171C and L408C were treated
with 20 M MTS cross-linker M8M before limited trypsin digestion with con-
centrations indicated in the figures. Partially digested fragments were
resolved with 4 –20% SDS-PAGE and Western blotting with mAb 13-4. The
band highlighted in the rectangle is shown separately at the bottom. The gray
arrow denotes the cross-linked fragment that moved faster than its uncross-
linked counterpart (black arrow).
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CL and NBD interactions were affected by PKA phosphoryla-
tion andATP binding. As shown in Fig. 2, B andC, of particular
interest are the interactions of theNBD1X-loop (Glu-543)with
both CL3 and CL4 and of the NBD2 X-loop (Asp-1341) with
CL1 and CL2. That the X-loops are in close proximity with the
ABC signature motif and with both CLs of opposite MSDs sug-
gest that the signals fromATP binding/hydrolysis at NBDsmay
be transmitted toMSDs through these interfaces. To determine
whether the interfacial interaction of Glu-543 with CL3 and
CL4 was indeed affected by PKA phosphorylation, membrane
vesicles fromHEKcells overexpressingCys-less CFTRwithCys
pairs E543C/T966C and E543C/T1057C were pretreated with
PKA in the presence of ATP and Mg2 before cross-linking
with various MTS reagents. As shown in Fig. 4A, similar to the
experiments with whole cells in membranes not treated with
PKA, the Cys pairs E543C/T966C and E543C/T1057C were
cross-linked by all the MTS reagents tested. The longer space
arm reagents produced stronger cross-linking. However, cross-
linking was neither augmented nor diminished by PKA treat-
ment, even though CFTR phosphorylation was confirmed by
the decreased signals detected using the phosphorylation-sen-
sitivemAb 450 (Fig. 4B). These results indicate that these inter-
faces remain in tight contact before and after exposure to stim-
uli that activate CFTR channels.
Unlike the X-loop that is unique in ABC exporters, the con-
tact between the CLs and the Q-loops of NBDs is conserved in
importers such as BtuCD, ModBC, HI1470/1, and the maltose
transporter as well as exporters such as Sav1866 and CFTR
(14–18). From the comparison of the crystal structures of the
nucleotide-free and the ATP-bound NBD of the MJ0796 ABC
transporter, it has been suggested that the conserved Q-loop
connecting the  and  subdomains of the NBDs moves along
with the ABC signature upon ATP binding (31). To verify
whether the two CFTR Q-loops (Gln-493 and Gln-1291)
undergo conformational changes in response to channel gating
stimuli, we first tested whether the cross-linking at the CL4/
NBD1 and CL2/NBD2 interfaces involving the Q-loops was
affected by PKA activating stimuli, and then we tested whether
the interface between the twoQ-loops themselves was changed
by PKA. As shown in Fig. 5, treatment of the cells with PKA
stimulation mixture before and during cross-linking had no
effect on cross-linking between either M498C/G1061C (Fig.
5A, left panel) or N268C/F1294C (Fig. 5B, left panel), although
phosphorylation-sensitive CFTR antibodymAb 450 confirmed
the phosphorylation of CFTR (Fig. 5, A and B, right panels).
However, when a Cys mutation was introduced in each Q-loop
(W496C/K1292C), the PKA stimulation mixture significantly
increased the cross-linking of this Cys pair with all MTS
reagents tested (Fig. 5C). The very weak cross-linking observed
in control cells may represent the basal PKA activity. Enhanced
interaction between the twoNBDs promoted by PKAphospho-
rylation was also observed byMense et al. (32) in split halves of
CFTR.
Influence of CL/NBD Cross-linking on Channel Gating—We
foundpreviously that cross-linking across either of the domain-
swapping interfaces between NBDs and CLs in opposite halves
ofCFTR rapidly and reversibly arrested channel gating (19).We
have now begun to analyze the influence of cross-linking across
the newly detected interfaces between NBDs and CLs on the
same side of the molecule in addition to the domain-swapping
interfaces, and quite different effects were observed. First,
cross-linking between residuesM961C and L1261C at the CL3/
NBD2 interface changed channel gating behavior substantially
but did not arrest it completely (Fig. 6A). The channel open
probability (Po) gradually decreased from 0.28 to 0.05 because
FIGURE 4. Phosphorylation of CFTR by PKA does not interfere with NBD1
X-loop binding to CL3 and CL4. Membrane vesicles prepared from HEK cells
transiently transfected with Cys pairs introduced at E543C with T966C (CL3)
and T1064C (CL4) were pretreated with PKA catalytic subunit in the presence
of ATP before incubating with 20 M MTS reagents. A, CFTR and cross-linked
bands were detected with mAb 596. B, CFTR phosphorylation was confirmed
with the phosphorylation-sensitive antibody mAb 450. X, C, and B represent
the cross-linked, the mature complex glycosylated, and the immature core
glycosylated CFTR, respectively.
FIGURE 5. Phosphorylation brings together the Q-loops of NBD1 and
NBD2. Transiently transfected HEK cells were pretreated with phosphoryla-
tion stimulation mixture (10 M forskolin, 100 M DiBu-cAMP, and 1 mM
3-isobutyl-1-methylxanthine) for 10 min. Cross-linking was carried out in the
presence of phosphorylation stimuli and detected as described in the legend
to Fig. 2. Cys pairs were introduced at: A interface between NBD1 Q-loop and
CL4 (M498C/G1061C); B, interface between NBD2 Q-loop and CL2 (N268C/
F1294C); or C, both Q-loops (W496C and K1292C). X, C, and B, represent the
cross-linked, the mature complex glycosylated, and the immature core glyco-
sylated CFTR, respectively.
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of reduction in open burst duration from 450 to 140ms. Simple
chemical modification of both available sulfhydryl groups by
the negatively chargedmonofunctionalMTSES reagent did not
affect channel gating in control experiments. However, the
brief openings of 140-ms duration at 30 °C observed after the
treatment with the M8M cross-linker are typical of NBD2
CFTR channel gating (9). Thus, the cross-linking between CL3
and NBD2 has an effect similar to that of the complete absence
of NBD2. In contrast, the cross-linking between residues
T996C and E543C at the CL3/NBD1 interface rapidly and
reversibly arrested channel gating (Fig. 6B) exactly as we had
observed previously with the CL4/NBD1 interface (19). The
control treatment of this cysteine pair with the MTSES sulfhy-
dryl reagent did not cause any substantial changes in the chan-
nel gating. Turning from the effects of cross-linking CL3 to
those of its counterpart, CL1 in the N-terminal MSD, its cross-
linking to NBD1 i.e.V171C/L408C had essentially no influence
on gating (Fig. 6C). On the other hand, the cross-linking
between L172C of CL1 and D1341C of NBD2 rapidly and
reversibly inhibited channel gating (Fig. 6D) very similar to
what we had observed previously for the CL2/NBD2 interface
(19). However, in the case of the completely reversible cessation
of gating caused by L172C/D1341C cross-linking, the role of
modification of each of these cysteines individually will have to
be studied in detail because treatment with monofunctional
MTSES also inhibited gating. Nevertheless, the present data
together with those reported earlier demonstrate that fixa-
tion of the two sides of these interdomain joints with respect
to each other has major but varied effects on channel activ-
ity. The coordinates of the CFTR model are available from
our earlier report (19).
DISCUSSION
Knowledge of the three-dimensional structure of CFTR will
lead to a fuller understanding of how disease-associated muta-
tions compromise its maturation
and channel activity and facilitate
the development of drugs to rescue
maturation and restore function. As
of yet, there is no known high reso-
lution structure of eukaryotic ABC
transporters; thus, we had con-
structed a CFTR three-dimensional
structure using molecular modeling
based on Sav1866, whose structure
has been determined to a resolution
of 3.0 Å by x-ray crystallography.
Several aspects of the model have
been experimentally confirmed
(19), including the crucial interface
between Phe-508 in NBD1 and CL4
of MSD2 and that between NBD2
and CL2. We have established that
these interfaces are important in
both the stabilization of CFTR
structure during biosynthesis and
the regulation of channel gating.
Using independent techniques such
as chemical cross-linking and REFER analysis, we found that
the CL2/NBD2 andCL4/NBD1 interfacesmay act as joints that
coordinatemovements ofNBDs andMSDs during channel gat-
ing. The CL4/NBD1 interface has also been identified by cross-
linking in the multidrug resistance P-glycoprotein (33). How-
ever, counterparts of none of the other CL/NBD interfaces
observed in Sav1866 structure have been confirmed in any
eukaryotic ABC proteins. In this study, we have detected the
interaction of all four CLs with both NBD1 and NBD2 (Fig. 1)
and analyzed the effect of PKA phosphorylation andATP bind-
ing on these interactions.We also observed distinctive effects of
cross-linking of various CL/NBD interfaces on channel gating.
Unlike solute importers such as BtuCD, ModBC, HI1470/1,
and themaltose transporter, all of which showMSDs that are in
contact with only one NBD, the architecture of the exporter
Sav1866 shows each MSD in contact with both NBDs. Like
P-glycoprotein, Sav1866 is a member of the multidrug resist-
ance class of ABC transporters. Sequence alignment of P-gly-
coprotein with Sav1866 and biochemical evidence confirm that
CL4 of MSD2 is in close proximity with NBD1, as Arg-905 and
Ser-909 of CL4 can be chemically cross-linked to Ser-474 and
Leu-443 of NBD1, respectively, when these residues are
replaced with cysteines in a Cys-less P-glycoprotein (33). As a
member of the exporter subclass of ABC proteins, CFTR may
share many structural features with Sav1866 and P-glycopro-
tein. In this study, we show that the CL and NBD interfaces
involve aromatic clusters that may stabilize the interface, and
theQ-loops and the X-loops that are close to ATP binding sites
(Fig. 2). Each NBD is in close contact with three CLs. These
stable interactions between NBDs and CLs facilitate their abil-
ity to couple the signals of ATP binding and hydrolysis at NBDs
to the channel gating at MSDs. The presence of the unique
X-loop in exporters but not importers suggests a distinct cou-
pling mechanism between the different subclasses of ABC
FIGURE 6. Role of interdomain cross-linking in CFTR channel gating. All single channel measurements
began with 20-min control recordings of each Cys pair CFTR variant. Open probabilities (Po) were calculated
from the all points histogram for the last 10 min of the recordings. However, only 2 min of control single
channel recording are shown in the first column. The functional state after 30 min of exposure to 20 M M8M
from the cis side of the bilayer is shown in the second column. The result of sulfhydryl group restoration 40 min
after exposure to 10 mM DTT subsequent to the M8M treatment is shown in the third column. In each panel, the
first three columns represent the results of the same 3-step experimental protocol. The effect of sulfhydryl
modification by monofunctional MTSES is shown in the fourth column. Both experimental and control proto-
cols were repeated at least three times for all Cys-less variants. A, M961C/L1261C at the CL3/NBD2 interface;
B, T966C/E543C at the CL3/NBD1 interface; C, V171C/L408C at the CL1/NBD1 interface; D, L171C/D1341C at the
CL1/NBD2 interface.
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transporters and that CFTR apparently employs that of the
exporters.
The contact interfaces between NBD1 with CL3 and CL4
involve an aromatic cluster, theQ-loop, and the X-loop (Fig. 2).
These close interactions between NBD1 with CL3 and CL4,
both in MSD2, may explain the observation that MSD2 is
required for CFTR maturation (9). Stepwise truncation of the
C-terminal region shows that CFTR is able to mature and
acquire channel activity when truncated back to residue Glu-
1172, just C-terminal of MSD2 (9). Younger et al. (34) also
demonstrated the requirement ofMSD2 for wild-type CFTR to
avoid ER quality control and degradation. They show that a
folding defect inF508 detected byRMA1 involves the inability
of MSD2 to interact with N-terminal domains. Analogous to
the NBD1 interaction with three CLs (CL1, CL3, and CL4),
NBD2 also interacts with three CLs (CL1, CL2, and CL3).
Moreover, similar to the interactions formed by NBD1, NBD2
contacts with the CLs also involve an aromatic cluster, the
Q-loop and the X-loop (Fig. 2). However, our observations that
NBD2-CFTR can still mature, reach the plasma membrane,
and retain channel function, although not as active as full-
lengthCFTR (9), suggest that the interfaces involvingNBD2 are
not as important in promoting CFTR conformational matura-
tion as those formed by NBD1 with the CLs. This finding also
rationalizes the existence of far fewer maturation-compromis-
ing, disease-associated mutations in NBD2 than in NBD1.
However, NBD2 becomes more sensitive to trypsin digestion
when mutations are introduced at CL4/NBD1 interfaces (9),
indicating that the proper folding of NBD2 itself requires a cor-
rect assembly of the preceding domains.
While theNBD2/CL interfaces appear to be not as important
in the biogenesis of CFTR as those at NBD1/CL, both sets are
still integral to the transmission of channel gating signals from
the nucleotide-binding sites to the transmembrane pore. This is
partially supported by the observation that co-expression of an
NBD2 fragment with NBD2-CFTR increases the channel
activity of NBD2-CFTR.4 This difference in function of the
various contact interfaces may be due to the fact that the CFTR
protein comprises pairs of similar but not identical membrane
and cytoplasmic domains in a single polypeptide; thus corre-
sponding interfaces from the two halves of the protein are not
exactly identical.
Signals of ATP binding and hydrolysis at NBDs need to be
transmitted to MSDs to regulate channel gating. Q-loops and
X-loops are in close proximity to CLs connecting MSDs and
also to theATP-binding sites. The close contacts of theQ-loops
with both the CLs and the ATP binding sites suggest that these
structural elements are appropriately located to transmit the
impact of ATP binding to the MSDs. In the multidrug ABC
transporter BmrA, cross-linking experiments showed that the
Q-loop disengages from CL1 during its catalytic cycle (29). In
yet another transporter, MJ0796, the comparison of the crystal
structures of the nucleotide-free and theATP-boundNBD sug-
gest that the Q-loop moves along with the LSGGQ motif such
that the amide side chain of Gln-90 at the N terminus of the
-phosphate linker moves 5 Å to contact the Na cofactor
and putative hydrolytic water in the active site (31). In P-glyco-
protein, the trapping of AMP-PNP or ADP plus vanadate at
NBD reduces the cross-linking of L443C and S909C, suggesting
that conformational changes occur at the NBD1/MSD2 inter-
face during the ATP catalytic cycle (33). In our study, we find
that the Q-loops of CFTRNBD1 andNBD2 form contacts with
CL4 and CL2, respectively. These contacts are formed before
and maintained during and after channel activation. While the
two NBDs come closer together during the stimulation that
activatesCFTR channels, the interfaces betweenCLs andNBDs
remain in proximity andmay coordinate larger conformational
changes on both sides of the contacts. These results, consistent
with our previous findings, suggest that these contact interfaces
move in unison in response to channel gating signals, and act as
connecting joints between the NBD/MSD interfaces. We can-
not however rule out the possibility that cross-linking is unable
to resolve the small conformational changes at these interfaces
during channel gating.
In our previous study, we found that cross-linking of the
domain-swapping interfaces at either CL2/NBD2 or CL4/
NBD1 reversibly arrested channel gating (19). Similar results
are found in this study on cross-linking of domain-swapping
interfaces at CL3/NBD1 andCL1/NBD2 (Fig. 6,B andD). How-
ever, cross-linking of Cys pairs between CLs and NBDs in the
same half of the molecule (CL3/NBD2 and CL1/NBD1) has
different effects on channel gating (Fig. 6, A and B). In the case
of CL1/NBD1, cross-linking has no substantial effect at all,
while for CL3/NBD2, channel gating is not completely arrested
by cross-linking but is substantially diminished due to a reduc-
tion in open burst duration from 450 to 140 ms. Brief openings
of 140-ms duration are typical forNBD2CFTRchannel gating
(9). We speculate that CL3/NBD2 cross-linking precludes the
influence of NBD2 on the ion channel gating. A specific feature
of NBD2 CFTR channel gating is its independence of nucleo-
tide type. The ion channel gating ligand specificity (24) is a
property of NBD24 and could be used as an independent test of
the type of channel gating after CL3 and NBD2 cross-linking.
These data confirm our previous conclusion about correspond-
ing domain-swapping interactions betweenNBDs andCLs (19)
and establish an important potential role of CL3 in allosteric
regulation between nucleotide binding and channel gating.
The three-dimensional CFTRmodel we constructed is based
on the crystal structures of Sav1866 (14) and human CFTR
NBD1 (10) and a homology model of NBD2 (35). The model
accommodates the experimental data on the orientation and
packing of transmembrane helices (36, 37), the inter-NBD
cross-linking (32), and our cross-linking experiments between
CLs and NBDs (19). A particular feature, the NBD1 RI loop,
adopts different conformations in several crystal structures of
CFTR NBD1 (26, 38), which suggests that the loop is highly
dynamic. In our CFTRmodel that we constructed following the
Sav1866 nucleotide bound conformation, the RI loop is
“flipped” away from theNBD1-NBD2 interface to avoid serious
clashes with NBD2 (19). Attempts to verify this conformation
by cross-linking CL1 and RI did not yield positive results (data
not shown). On the other hand, another viable conformation
for the RI region is suggested by themouse CFTRNBD1, which4 J. R. Riordan, unpublished results.
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shows its RI “flipped” toward the NBD1/NBD2 interface and
theCL1 (26).Wehave verified the latter conformation by intro-
ducing Cys pairs in CL1 and different residues in RI (V171C/
E407C, V171C/L408C) and showing that these pairs can be
cross-linked byM8M(Fig. 3B). It is noteworthy that theRI loop,
when positioned in the NBD1-NBD2 interface, does not clash
with NBD2 when the CFTR NBDs associate according to the
closed nucleotide-free conformation of MsbA (25). Although
there is one report that CL1 binds to NBD1 in a PKA-depend-
ent manner using a synthetic CL1 peptide and purified NBD1
(30), in our experiments with functional membrane-bound
CFTR, the binding of CL1 with RI is not affected by PKA phos-
phorylation (supplemental Fig. 2B).
We have identified the interfaces between CFTR nucleotide
binding domains and the cytoplasmic loops of the membrane-
spanning domains. These interfaces are significantly involved
in the stabilization of interdomain contacts and regulation of
the channel gating. Our results shed new light on the structure
and mechanism of action of CFTR, the only known ABC trans-
porter shown to function as an ion channel. Identification of
these interdomain interfaces and understanding of how they
are perturbed by disease-associated mutations may also aid
efforts to develop new therapeutic strategies to treat cystic
fibrosis.
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